Antibiotic — broad-spectrum
Chloramphenicol
Brand names: Chloromycetin, Optrex Infected Eyes
Adult dose
Dose: Eye drops 0.5%: 1 drop 2-hourly for 48h, then QDS for 5 days. Eye ointment 1% nocte. Systemic: 50mg/kg/day in 4 divided doses (life-threatening infection only)
Route: Topical/IV/PO
Frequency: varies
Paediatric dose
Dose: 12.5 mg/kg
Route: IV
Frequency: Every 6 hours (4 divided doses; total 50 mg/kg/day)
Max: 1 g per dose (4 g/day)
BNFc child 1 month–18 years: 12.5 mg/kg every 6 hours IV (50 mg/kg/day) for severe infection; up to 25 mg/kg every 6 h (100 mg/kg/day) for life-threatening infection (e.g. H. influenzae meningitis), reduced once response achieved. Plasma-concentration monitoring essential. Topical eye drops widely used in children >2 years. AVOID in neonates (grey baby syndrome).
Paediatric weight-based calculator
BNFc child 1 month–18 years: 12.5 mg/kg every 6 hours IV (50 mg/kg/day) for severe infection; up to 25 mg/kg every 6 h (100 mg/kg/day) for life-threatening infection (e.g. H. influenzae meningitis), reduced once response achieved. Plasma-concentration monitoring essential. Topical eye drops widely used in children >2 years. AVOID in neonates (grey baby syndrome).
Clinical pearls
- Topical use first-line for bacterial conjunctivitis
- Systemic use restricted to life-threatening infections (e.g. typhoid, H. influenzae meningitis where alternatives unsuitable)
Contraindications
- History of bone marrow toxicity
- Avoid in 3rd trimester pregnancy and neonates (grey baby syndrome)
Side effects
- Aplastic anaemia (rare, idiosyncratic)
- Reversible bone marrow depression
- Optic neuritis (prolonged use)
- Grey baby syndrome in neonates
Interactions
- Increases warfarin, phenytoin, sulfonylurea levels (CYP2C9 inhibitor)
Monitoring
- FBC for systemic use
- Plasma levels in neonates
Reference: BNFc; BNF; NICE CKS; https://bnf.nice.org.uk/drugs/chloramphenicol/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- Centor / McIsaac Score for Strep Pharyngitis · Throat
- FeverPAIN Score for Strep Throat · Throat
- Jarisch-Herxheimer Reaction Severity Assessment · Treatment Reactions
- PID Severity (CDC Diagnostic Criteria) · Gynaecological Infections
- Primary Angle Closure Disease Spectrum (PACS / PAC / PACG) · Glaucoma
- Gustilo-Anderson Classification (Open Fractures) · Fracture Classification
Pathways
- Infective Endocarditis · ESC 2023 Infective Endocarditis Guidelines; NICE NG41
- Eczema Herpeticum · BAD; NICE CKS
- Suspected Bacterial Meningitis (Adult) · NICE NG240 (2024); NICE NG143 (paeds)
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021
- Returning Traveller — Fever · NaTHNaC; PHE; ESCMID 2018
- Malaria — Diagnosis & Management · PHE 2016; WHO 2023